Robatumumab (English Wikipedia)

Analysis of information sources in references of the Wikipedia article "Robatumumab" in English language version.

refsWebsite

Global rank English rank

4^th place

4^th place

195^th place

302^nd place

2^nd place

2^nd place

1clinicaltrials.gov

5,225^th place

4,062^nd place

274^th place

309^th place

clinicaltrials.gov (Global: 5,225^th place; English: 4,062^nd place)

Clinical trial number NCT00551213 for "A Study to Determine the Activity of Robatumumab (SCH 717454, MK-7454) in Participants With Relapsed or Recurrent Colorectal Cancer (P04721, MK-7454-003)" at ClinicalTrials.gov

doi.org (Global: 2^nd place; English: 2^nd place)

Anderson PM, Bielack SS, Gorlick RG, Skubitz K, Daw NC, Herzog CE, et al. (October 2016). "A phase II study of clinical activity of SCH 717454 (robatumumab) in patients with relapsed osteosarcoma and Ewing sarcoma". Pediatric Blood & Cancer. 63 (10): 1761–70. doi:10.1002/pbc.26087. PMC 5129487. PMID 27362300.

nih.gov (Global: 4^th place; English: 4^th place)

ncbi.nlm.nih.gov

Anderson PM, Bielack SS, Gorlick RG, Skubitz K, Daw NC, Herzog CE, et al. (October 2016). "A phase II study of clinical activity of SCH 717454 (robatumumab) in patients with relapsed osteosarcoma and Ewing sarcoma". Pediatric Blood & Cancer. 63 (10): 1761–70. doi:10.1002/pbc.26087. PMC 5129487. PMID 27362300.

pubmed.ncbi.nlm.nih.gov

Anderson PM, Bielack SS, Gorlick RG, Skubitz K, Daw NC, Herzog CE, et al. (October 2016). "A phase II study of clinical activity of SCH 717454 (robatumumab) in patients with relapsed osteosarcoma and Ewing sarcoma". Pediatric Blood & Cancer. 63 (10): 1761–70. doi:10.1002/pbc.26087. PMC 5129487. PMID 27362300.

springer.com (Global: 274^th place; English: 309^th place)

adisinsight.springer.com

"Robatumumab". Adis Insight. Springer Nature Switzerland AG.

who.int (Global: 195^th place; English: 302^nd place)

"robatumumab", p. 337 in: Quality Assurance and Safety of Medicines (2008). Encrenaz C (ed.). "Proposed International Nonproprietary Names: List 100" (PDF). WHO Drug Information. 22 (4): 311–67.